BioUtah, the industry association for Utah's life science community, announced the final program for the 2015 Utah Life Science Summit, "Impacting Global Industry Trends through Advocacy and Innovation."
The sixth annual meeting of Utah's premier annual life science event will be held Thursday, November 5, at the Hilton Salt Lake City Center in Salt Lake City, Utah. The Summit provides unsurpassed networking opportunities, and features presentations from top industry, government and education leaders. The Utah Life Science Summit is presented annually by BioUtah and its affiliated 501(c)(3), BioUtah Institute, both of which serve Utah organizations focused on medical devices, diagnostics, biotech, pharma, healthcare and supporting products and services.
"The 2015 Utah Life Science Summit incorporates local and federal leaders, exploring the most critical topics impacting our industry. The quality and diversity of the speakers are part of what makes this the state’s most desirable life science event,” said Kelly Slone, President and CEO of BioUtah. "The summit provides excellent opportunities to build and solidify key connections, updates about the current trends and initiatives shaping our sector, and interactive learning experiences to keep the industry educated with cutting-edge information.”
The 2015 Summit will feature three plenary sessions: a breakfast keynote session; the Utah Life Science Awards, where Governor Gary Herbert will be the keynote luncheon speaker; and a closing session for participants to collaborate on lessons learned and plan next steps to propel the industry forward.
An excellent list of prestigious national and local speakers will be discussing a variety of "hot" topics affecting the life science industry. Exhibitors will also be present during the meeting. New this year, we will unveil Innovation Exhibits during the afternoon, which will feature the most innovative start-up technologies in Utah.
Confirmed speakers include:
Jeff Shuren, Director for the Center for Devices and Radiological Health (CDRH), will participate via video conference and will highlight FDA’s priorities for next year’s FDA user fee reauthorization and will answer questions from the participants.
Latonya Mitchell, Regional Director, HHS/FDA, and Ginger Sykes, SCSO, HHS/FDA, will participate in a roundtable discussion and provide an FDA update on FDA’s regional efforts and priorities and initiatives.
Andrew Croshaw, President, Leavitt Partners, will be the breakfast keynote and will focus on navigating the new healthcare economy and the challenging times of transitioning from a fee-for-service model to value-based health care delivery models.
There are several sessions planned including: learning about promising research and innovations coming out of Utah’s universities; discussing key public policies impacting the industry; providing a dialogue on global market trends; and key regulations impacting the industry. We have planned an investor/CEO and entrepreneur mentoring session as well.
Agenda and registration information for the summit is available at: http://utahlifesciencesummit.com.
